You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-androgen Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)

Recruiting
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Antiandrogen Therapy
  • +5 more
  • Duarte, California
  • +15 more
Jan 24, 2023

Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)

Completed
  • Transgender Women
  • Estradiol
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    Faculty of Sports Science, Chulalongkorn University
Nov 2, 2023

PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7

Active, not recruiting
  • PSA Level Greater Than 0.03
  • +4 more
  • Antiandrogen Therapy
  • +2 more
  • Los Angeles, California
  • +1 more
Oct 14, 2021

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Efficacy After Anti-androgen Therapy for CRPC

Active, not recruiting
  • Castration Resistant Prostate Cancer (CRPC)
    • (no location specified)
    Jan 5, 2021

    Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

    Recruiting
    • Cancer of Prostate
    • Aalst, Belgium
    • +8 more
    Aug 4, 2021

    Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

    Not yet recruiting
    • Locally Advanced Salivary Gland Carcinoma
    • +3 more
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 10, 2023

    Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

    Active, not recruiting
    • Prostate Cancer
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Dec 7, 2020

    Prostate Cancer Trial in Boston, Brooklyn, New York (225Ac-J591, Pembrolizumab, Androgen receptor pathway inhibitor)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +3 more
    Sep 20, 2021

    Prostate Cancer Trial (iMAB, cMAB)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jul 26, 2023

    Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

    Active, not recruiting
    • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
    • Docetaxel injection
    • +2 more
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 24, 2022

    Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

    Completed
    • Stage I Prostate Adenocarcinoma
    • +2 more
    • Antiandrogen Therapy
    • +3 more
    • Detroit, Michigan
    • +2 more
    Oct 4, 2020

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • New Haven, Connecticut
      Yale Cancer Center
    Oct 20, 2023

    Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 11, 2022

    Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

    Not yet recruiting
    • Castration Sensitive Prostate Cancer
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 12, 2023

    Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Androgen deprivation therapy (ADT)
    • +3 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center Seidman Cancer Cen
    Nov 21, 2023

    Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Product
    • +2 more
    • Cincinnati, Ohio
      University of Cincinnati Medical Center
    Mar 27, 2023

    Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

    Not yet recruiting
    • Androgen Deprivation Therapy
    • +4 more
    • Gonadotropin-Releasing Hormone Agonist
    • +2 more
    • (no location specified)
    Jan 18, 2023

    Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

    Recruiting
    • Castration-Resistant Prostatic Cancer
    • +4 more
    • Orange City, Florida
    • +1 more
    Nov 23, 2022

    Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • Radiation Therapy
    • Androgen Deprivation Therapy (ADT)
    • Washington, District of Columbia
    • +2 more
    Oct 25, 2022